According to a recent article in the Toronto Star, Canadians should be worried about defective or sub-standard pharmaceutical drugs found in our pharmacies.
But researchers at the University of Toronto’s Institute of Biomaterials & Biomedical Engineering (IBBME) say other areas of the world face an epidemic of defective drugs – and they say that needs to change.
Professor Peter Zandstra and PhD students Yonatan Lipsitz and Nimalan Thavandiran are one of two groups at IBBME recently awarded Grand Challenges Canada grants. The team is developing a new tool for drug sellers to test heart medication for additives or other problems.
Continue reading at UofT News.